Mirae Asset Global Investments »

Seelos Therapeutics Ord shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $422k 304k 1.39

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Intuitive Surgical Com New (ISRG)
Qualcomm (QCOM)

View all positions for Mirae Asset Global Investments

Top funds holding Seelos Therapeutics Ord

Wealth Effects
Vanguard Group
Balyasny Asset Management
Jeffrey L. Gendell
Modera Wealth Management
Citadel Advisors
Lynwood Capital Management
Strategic Family Wealth Counselors
Two Sigma Investments
CRA Financial Services
Wealth Enhancement Advisory Services
Advisor Group Holdings
Carmichael Hill & Associates
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Seelos Therapeutics Ord